168 related articles for article (PubMed ID: 7648981)
1. Biliary alpha 1-acid glycoprotein concentrations in gallstone-free controls and in patients with multiple or solitary cholesterol gallstones.
Nuutinen H; Abei M; Schwarzendrube J; Ginanni Corradini S; Walsh RM; Kawczak P; Holzbach RT
Dig Dis Sci; 1995 Aug; 40(8):1786-91. PubMed ID: 7648981
[TBL] [Abstract][Full Text] [Related]
2. Correlation between biliary alpha 1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease.
Nuutinen H; Ginanni Corradini S; Jüngst D; Lange V; Abei M; Schwarzendrube J; Williams C; Holzbach RT
Dig Dis Sci; 1995 Jun; 40(6):1174-8. PubMed ID: 7781430
[TBL] [Abstract][Full Text] [Related]
3. Biliary haptoglobin, a potent promoter of cholesterol crystallization at physiological concentrations.
Yamashita G; Ginanni Corradini S; Secknus R; Takabayashi A; Williams C; Hays L; Chernosky AL; Holzbach RT
J Lipid Res; 1995 Jun; 36(6):1325-33. PubMed ID: 7666009
[TBL] [Abstract][Full Text] [Related]
4. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
Gustafsson U; Sahlin S; Einarsson C
Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
[TBL] [Abstract][Full Text] [Related]
5. Variations in pigment and carbohydrate content of gallbladder bile affect accurate quantitation of total protein when using the fluorescamine method.
Ginanni Corradini S; Yamashita G; Nuutinen H; Chernosky A; Williams C; Hays L; Shiffman ML; Walsh RM; Svanvik J; Della Guardia P; Capocaccia L; Holzbach RT
Scand J Gastroenterol; 1997 Apr; 32(4):340-9. PubMed ID: 9140156
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol crystallization-promoters in human bile: comparative potencies of immunoglobulins, alpha 1-acid glycoprotein, phospholipase C, and aminopeptidase N1.
Abei M; Schwarzendrube J; Nuutinen H; Broughan TA; Kawczak P; Williams C; Holzbach RT
J Lipid Res; 1993 Jul; 34(7):1141-8. PubMed ID: 8103787
[TBL] [Abstract][Full Text] [Related]
7. Nucleation time and fatty acid composition of lecithin in human gallbladder bile.
Hatsushika S; Tazuma S; Kajiyama G
Scand J Gastroenterol; 1993 Feb; 28(2):131-6. PubMed ID: 8441906
[TBL] [Abstract][Full Text] [Related]
8. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
[TBL] [Abstract][Full Text] [Related]
9. The relation between biliary lipids, nucleation time, and number of gallbladder stones after percutaneous gallbladder puncture.
Tudyka J; Kratzer W; Maier C; Mason R; Wechsler JG
Scand J Gastroenterol; 1994 Sep; 29(9):844-8. PubMed ID: 7824866
[TBL] [Abstract][Full Text] [Related]
10. Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones.
Hasegawa T; Makino I
J Gastroenterol; 1995 Feb; 30(1):96-102. PubMed ID: 7719423
[TBL] [Abstract][Full Text] [Related]
11. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.
Portincasa P; Di Ciaula A; Vendemiale G; Palmieri V; Moschetta A; Vanberge-Henegouwen GP; Palasciano G
Eur J Clin Invest; 2000 Apr; 30(4):317-24. PubMed ID: 10759880
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones.
Jüngst D; Lang T; von Ritter C; Pratschke E; Paumgartner G
Hepatology; 1992 May; 15(5):804-8. PubMed ID: 1568721
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile.
Fischer S; Dolu MH; Zündt B; Meyer G; Geisler S; Jüngst D
Eur J Clin Invest; 2001 Sep; 31(9):789-95. PubMed ID: 11589721
[TBL] [Abstract][Full Text] [Related]
14. Increased biliary protein precedes gallstone formation.
Moser AJ; Abedin MZ; Roslyn JJ
Dig Dis Sci; 1994 Jun; 39(6):1313-20. PubMed ID: 8200266
[TBL] [Abstract][Full Text] [Related]
15. Solitary versus multiple gallstones: the importance of total biliary protein concentration and other factors.
Tudyka J; Kratzer W; Kuhn K; Mason R; Wechsler JG; Adler G
Hepatogastroenterology; 1995; 42(5):638-44. PubMed ID: 8751227
[TBL] [Abstract][Full Text] [Related]
16. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate.
Chijiwa K; Hirota I; Noshiro H
Gastroenterol Jpn; 1992 Feb; 27(1):88-94. PubMed ID: 1555751
[TBL] [Abstract][Full Text] [Related]
17. High vesicular cholesterol and protein in bile are associated with formation of cholesterol but not pigment gallstones.
Chijiiwa K; Hirota I; Noshiro H
Dig Dis Sci; 1993 Jan; 38(1):161-6. PubMed ID: 8420750
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin decreases viscosity of gallbladder bile in patients with cholesterol gallstone disease.
von Ritter C; Niemeyer A; Lange V; Möhrle W; Richter WO; von Meyer L; Brandl H; del Pozo R; Jüngst D
Clin Investig; 1993 Nov; 71(11):928-32. PubMed ID: 8312687
[TBL] [Abstract][Full Text] [Related]
19. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease.
Groen AK; Noordam C; Drapers JA; Egbers P; Jansen PL; Tytgat GN
Hepatology; 1990 Apr; 11(4):525-33. PubMed ID: 2328950
[TBL] [Abstract][Full Text] [Related]
20. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K
Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
